Day One Biopharmaceuticals, Inc.
DAWN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 17.4% | 10.2% | 5.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 88.7% | 88.9% | 90.6% | 89.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -47.2% | -86.6% | -114.1% | -200.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -49.6% | -89.4% | -117% | -225% |
| EPS Diluted | -0.19 | -0.29 | -0.35 | -0.7 |
| % Growth | 34.5% | 17.1% | 50% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |